Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1111/ejh.13491

http://scihub22266oqcxt.onion/10.1111/ejh.13491
suck pdf from google scholar
32663356!7404736!32663356
unlimited free pdf from europmc32663356    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32663356      Eur+J+Haematol 2020 ; 105 (5): 540-546
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Haematological manifestations of COVID-19: From cytopenia to coagulopathy #MMPMID32663356
  • Agbuduwe C; Basu S
  • Eur J Haematol 2020[Nov]; 105 (5): 540-546 PMID32663356show ga
  • Emerging data from the management of patients with coronavirus disease 2019 (COVID-19) suggests multi-systemic involvement, including the hemopoietic system. The haematological manifestations of COVID-19 include blood count anomalies notably lymphopenia and neutrophilia which are of prognostic significance. Hyperferritinemia and elevated lactate dehydrogenase have also been associated with increased mortality. Furthermore, there is considerable evidence of a distinct coagulopathy associated with COVID-19 characterised by elevated D-dimers and an increased risk of thrombotic events. This comprehensive review summarises the latest evidence from published studies and discusses the implications of the various haematological manifestations of COVID-19 with a view to guiding clinical management and risk stratification in this rapidly evolving pandemic.
  • |Anticoagulants/therapeutic use[MESH]
  • |Biomarkers/blood[MESH]
  • |Blood Coagulation Disorders/blood/drug therapy/*etiology[MESH]
  • |COVID-19 Drug Treatment[MESH]
  • |COVID-19/*blood/*complications[MESH]
  • |Cytokine Release Syndrome/blood/etiology[MESH]
  • |Fibrin Fibrinogen Degradation Products/metabolism[MESH]
  • |Humans[MESH]
  • |Inflammation Mediators/blood[MESH]
  • |Leukocyte Disorders/blood/etiology[MESH]
  • |Lymphocyte Count[MESH]
  • |Lymphopenia/blood/*etiology[MESH]
  • |Neutrophils[MESH]
  • |Pandemics[MESH]
  • |Risk Factors[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box